Sei Investments CO Veracyte, Inc. Transaction History

Sei Investments CO

$74.7 Billion
Q3 2024

A detailed history of Sei Investments CO transactions in Veracyte, Inc. stock. As of the latest transaction made, Sei Investments CO holds 269,243 shares of VCYT stock, worth $10.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

269,243

Previous 148,629 81.15%

Holding current value

$10.6 Million

Previous $3.22 Million 184.53%

% of portfolio

0.01%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$21.0 - $35.25 $2.53 Million - $4.25 Million	120,614 Added 81.15%	269,243 $9.16 Million
Q2 2024 Aug 13, 2024	BUY	$18.86 - $23.55 $113,631 - $141,888	6,025 Added 4.22%	148,629 $3.22 Million
Q1 2024 May 07, 2024	BUY	$21.0 - $29.1 $523,845 - $725,899	24,945 Added 21.2%	142,604 $3.16 Million
Q4 2023 Feb 14, 2024	BUY	$19.72 - $28.68 $81,561 - $118,620	4,136 Added 3.64%	117,659 $3.24 Million
Q3 2023 Nov 14, 2023	SELL	$22.33 - $29.92 $356,654 - $477,882	-15,972 Reduced 12.33%	113,523 $2.53 Million
Q2 2023 Aug 11, 2023	SELL	$20.96 - $26.99 $165,206 - $212,735	-7,882 Reduced 5.74%	129,495 $3.3 Million
Q1 2023 May 12, 2023	BUY	$20.58 - $27.89 $275,298 - $373,084	13,377 Added 10.79%	137,377 $3.06 Million
Q4 2022 Feb 10, 2023	BUY	$15.31 - $29.94 $376,947 - $737,152	24,621 Added 24.77%	124,000 $2.94 Million
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $19,299 - $32,475	1,164 Added 1.19%	99,379 $1.65 Million
Q2 2022 Aug 15, 2022	BUY	$15.45 - $29.52 $135,975 - $259,805	8,801 Added 9.84%	98,215 $1.96 Million
Q1 2022 May 13, 2022	SELL	$21.94 - $42.51 $645,606 - $1.25 Million	-29,426 Reduced 24.76%	89,414 $2.47 Million
Q4 2021 Feb 14, 2022	BUY	$36.09 - $53.79 $683,544 - $1.02 Million	18,940 Added 18.96%	118,840 $4.9 Million
Q3 2021 Nov 12, 2021	BUY	$35.62 - $52.97 $364,962 - $542,730	10,246 Added 11.43%	99,900 $4.64 Million
Q2 2021 Aug 06, 2021	SELL	$32.94 - $56.62 $490,246 - $842,675	-14,883 Reduced 14.24%	89,654 $3.58 Million
Q1 2021 May 12, 2021	BUY	$44.47 - $81.38 $691,330 - $1.27 Million	15,546 Added 17.47%	104,537 $5.56 Million
Q4 2020 Feb 08, 2021	BUY	$32.49 - $61.88 $694,571 - $1.32 Million	21,378 Added 31.62%	88,991 $4.36 Million
Q3 2020 Dec 04, 2020	SELL	$26.73 - $35.67 $6,735 - $8,988	-252 Reduced 0.37%	67,613 $2.2 Million
Q3 2020 Nov 06, 2020	BUY	$26.73 - $35.67 $466,224 - $622,156	17,442 Added 34.59%	67,865 $2.2 Million
Q2 2020 Aug 17, 2020	BUY	$19.49 - $28.11 $429,676 - $619,713	22,046 Added 77.69%	50,423 $1.31 Million
Q2 2020 Aug 11, 2020	SELL	$19.49 - $28.11 $393,483 - $567,512	-20,189 Reduced 41.57%	28,377 $790,000
Q1 2020 May 14, 2020	BUY	$16.13 - $30.17 $283,678 - $530,599	17,587 Added 56.77%	48,566 $1.18 Million
Q4 2019 Feb 06, 2020	SELL	$20.78 - $29.99 $762,813 - $1.1 Million	-36,709 Reduced 54.23%	30,979 $864,000
Q3 2019 Nov 12, 2019	SELL	$23.87 - $30.93 $287,156 - $372,087	-12,030 Reduced 15.09%	67,688 $1.63 Million
Q2 2019 Aug 14, 2019	SELL	$22.1 - $28.56 $117,063 - $151,282	-5,297 Reduced 6.23%	79,718 $2.27 Million
Q1 2019 May 15, 2019	SELL	$12.0 - $25.76 $140,112 - $300,773	-11,676 Reduced 12.08%	85,015 $2.13 Million
Q4 2018 Feb 13, 2019	BUY	$9.15 - $14.85 $536,885 - $871,338	58,676 Added 154.35%	96,691 $1.1 Million
Q3 2018 Nov 08, 2018	BUY	$9.55 - $12.64 $363,043 - $480,509	38,015 New	38,015 $363,000
Q2 2018 Aug 03, 2018	SELL	$5.39 - $9.66 $458 - $821	-85 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$5.44 - $6.97 $239 - $306	-44 Reduced 34.11%	85 $0
Q4 2017 Feb 08, 2018	SELL	$6.05 - $9.37 $49,132 - $76,093	-8,121 Reduced 98.44%	129 $1,000
Q3 2017 Nov 06, 2017	BUY	$7.81 - $8.77 $64,432 - $72,352	8,250	8,250 $72,000

Others Institutions Holding VCYT

# of Institutions

308

Shares Held

81.8M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.81B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Veracyte, Inc. Transaction History